Cherry power: new drink fights skin damage from city life

NCT ID NCT07229131

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a daily drink made from acerola cherry powder could improve skin brightness and health in women exposed to pollution and blue light from screens. 108 healthy Chinese women aged 30-60 with dull skin took either the acerola drink or a placebo for 84 days. Researchers measured changes in skin translucency and radiance to see if the supplement helped counteract environmental stress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

Nov 2025

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 60 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Healthy women. 2. Chinese. 3. Age: in each group of products * 50% of subject having 30 to 45 years old * 50% of subject having 46 to 60 years old 4. Phototype: II to IV. 5. Subject with dull skin from grade 3 to 7 on skin dullness 9 points scale. 6. Subject exposed to high air pollution up to 2 to 3 hours per day (traffic roads, cigarette smoke, dusts or small particles). 7. Subject who accepts daily exposition to blue light (mobile phone, Ipad, laptop or get exposure to LED light) at home (at least 2h). 8. Subject with at least 1 spot on the face. 9. Subject with BMI ≤ 30 10. Subject, psychologically able to understand the study related information and to give a written informed consent. 11. Subject having given freely and expressly her informed consent. 12. Subject agreeing to not change her alimentary and cosmetic habits on the studied area during the study. Exclusion Criteria: In term of population : 1. Pregnant or nursing woman or planning a pregnancy during the study. 2. Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship. 3. Minor subject. 4. Major subject who is under guardianship or who is not able to express her consent. 5. Subject in a social or sanitary establishment. 6. Subject suspected to be non-compliant according to the investigator's judgment. In term of associated pathology : 7. Subject with a condition or receiving a medication which, in the investigator's judgment, put the subject at undue risk. 8. Subject suffering from a severe or progressive disease. 9. Subject with known history of or suffering from skin disease that may interfere with evaluation of the study results and/or subject safety. 10. Subject having history of severe allergy or anaphylactic shock including known risk of hypersensitivity to one of the components of the composition of the product Related to previous or ongoing treatment : 11. Subject undergoing a topical treatment on the test area or a systemic treatment: * anti-inflammatory medication and/or anti-histamines during the previous 2 weeks and during the study; * corticosteroids during the 2 previous weeks and during the study; * retinoids and/or immunosuppressors during the 3 previous months and during the study; * any medication stabilized for less than one month. 12. Subject having started or changed her oral contraceptive or any other hormonal treatment during the three previous months. 13. Subject having done facial skin care like peeling, mask… during the previous 2 weeks and during the study. 14. Subject having used oral nutritional supplements and/or vitamin supplementation during the previous month and during the study In term of lifestyle : 15. Intensive exposure to sunlight or UV-rays within the previous month and/or foreseen during the study; 16. Subject having used topical products containing actives substances during the previous 2 weeks and during the study 17. Subject planning to change her life habits during the study. 18. Subject with unstable eating habits or planning to change them during the study 19. Subject with an excessive consumption of alcohol (more than 2 glasses of wine per day) and/or tobacco (more than 5 cigarettes per day).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pollution; exposure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • EUROFINS CONSUMER PRODUCT TESTING (Guangzhou)Co.,Ltd.

    Guangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.